Related Experiment Video
Updated: May 23, 2026

Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
The J-curve revisited: a therapeutic dilemma
Edward J Filippone1, Andrew Foy
1Department of Medicine, Division of Nephrology, Thomas Jefferson University, Philadelphia, PA 18145, USA. kidneys@comcast.net
Insights
The hypertension J-curve shows increased cardiovascular risk when diastolic blood pressure (BP) drops too low, especially in coronary heart disease (CHD) patients. Recent studies support this phenomenon, impacting treatment strategies.
Area of Science:
- Cardiology
- Hypertension Research
- Clinical Medicine
Background:
- The J-curve phenomenon describes an increased risk of cardiovascular events when diastolic blood pressure (BP) falls below a specific threshold.
- This concept has been debated for over 30 years, particularly concerning its relevance in hypertension treatment.
Purpose of the Study:
- To review the existing literature on the J-curve phenomenon in hypertension treatment.
- To discuss the pathophysiology and evidence supporting or refuting the J-curve.
- To explore the clinical implications for managing hypertension in high-risk populations.
Main Methods:
- Comprehensive literature review of studies investigating the relationship between diastolic BP and cardiovascular outcomes.
- Analysis of post hoc data from large contemporary randomized trials, particularly in patients with coronary heart disease (CHD).
Main Results:
- Recent analyses of major randomized trials in patients with documented CHD provide strong evidence supporting the existence of the J-curve.
- The J-curve suggests that excessively low diastolic BP may increase cardiovascular morbidity and mortality.
Conclusions:
- The J-curve phenomenon is supported by contemporary evidence, particularly in patients with established coronary heart disease.
- Strict blood pressure control in hypertension requires careful consideration of the potential risks associated with achieving very low diastolic BP levels, especially in high-risk patients.
Abstract:
The J-curve in hypertension treatment refers to the relationship between achieved diastolic blood pressure (BP) and cardiovascular morbidity and mortality, specifically related to coronary heart disease (CHD). As diastolic BP decreases below a certain threshold or nadir, the risk of cardiovascular events increases. This phenomenon was first described over 30 years ago and its significance has been debated ever since. We review in detail the literature for and against the existence of this J-curve and discuss its purported pathophysiology. Most notably, recent post hoc analyses of large contemporary randomized trials in patients with documented CHD strongly support its existence. Given the current emphasis on strict BP control, especially in high-risk patients like those with CHD, diabetes, and chronic kidney disease, we discuss the implications this J-curve may have for treating hypertension in the individual patient.
Related Concept Videos
Dose Response Curve: Conventional Versus Nonmonotonic
Therapeutic Drug Monitoring: Affecting Factors
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Psychodynamic Therapy

